Insulin resistance despite tight glucose control is associated with mortality in critically Ill surgical patients

Journal of Intensive Care Medicine

Volumn 24, Issue 4, 2009, Pages 242-251

  Mowery, Nathan T ^a,c   Dortch, Marcus J ^b   Dossett, Lesly A ^a   Norris, Patrick R ^a   Diaz Jr , Jose J ^a   Morris Jr , John A ^a   May, Addison K ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Insulin resistance; Intensive care; Intensive insulin therapy; Physiologic monitoring; Stress hyperglycemia; Trauma

Indexed keywords

GLUCOSE; HYPERTENSIVE AGENT; INSULIN; STEROID;

ADULT; ASSISTED VENTILATION; BLOOD GLUCOSE MONITORING; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INJURY; INSULIN RESISTANCE; INTENSIVE CARE UNIT; LABORATORY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SURVIVOR;

BLOOD GLUCOSE; CRITICAL ILLNESS; FEMALE; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; WOUNDS AND INJURIES;

EID: 68349123812     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066609335663     Document Type: Review

References (49)

1. McCowen KC, Malhotra A., Bistrian BR Stress-induced hyperglycemia. Crit Care Clin. 2001 ; 17 (1). 107-124.
2. Gore DC, Chinkes D., Heggers J., Herndon DN, Wolf SE, Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma. 2001 ; 51 (3). 540-544.
3. Yendamuri S., Fulda GJ, Tinkoff GH Admission hyperglycemia as a prognostic indicator in trauma. J Trauma. 2003 ; 55 (1). 33-38.
4. Bochicchio GV, Sung J., Joshi M., et al. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma. 2005 ; 58 (5). 921-924.
5. Sung J., Bochicchio GV, Joshi M., Bochicchio K., Tracy K., Scalea TM Admission hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma. 2005 ; 59 (1). 80-83. (Pubitemid 41271642)
6. Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC Relationship of early hyperglycemia to mortality in trauma patients. J Trauma. 2004 ; 56 (5). 1058-1062.
7. Krinsley JS Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003 ; 78 (12). 1471-1478.
8. Fietsam R. Jr, Bassett J., Glover JL Complications of coronary artery surgery in diabetic patients. Am Surg. 1991 ; 57 (9). 551-557.
9. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ. 1997 ; 314 (7093). 1512-1515.
10. Malmberg K., Norhammar A., Wedel H., Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation. 1999 ; 99 (20). 2626-2632.
11. O'Neill PA, Davies I., Fullerton KJ, Bennett D. Stress hormone and blood glucose response following acute stroke in the elderly. Stroke. 1991 ; 22 (7). 842-847.
12. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke. 1999 ; 30 (4). 793-799.
13. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001 ; 345 (19). 1359-1367.
14. Ross H., Johnston ID, Welborn TA, Wright AD Effect of abdominal operation on glucose tolerance and serum levels of insulin, growth hormone, and hydrocortisone. Lancet. 1966 ; 2 (7463). 563-566.
15. Aarimaa M., Slatis P., Haapaniemi L., Jeglinsky B. Glucose tolerance and insulin response during and after elective skeletal surgery. Ann Surg. 1974 ; 179 (6). 926-929.
16. Clarke RS, Johnston H., Sheridan B. The influence of anaesthesia and surgery on plasma cortisol, insulin and free fatty acids. Br J Anaesth. 1970 ; 42 (4). 295-299.
17. Carlson GL Insulin resistance in sepsis. Br J Surg. 2003 ; 90 (3). 259-260.
18. Hill M., McCallum R. Altered transcriptional regulation of phosphoenolpyruvate carboxykinase in rats following endotoxin treatment. J Clin Invest. 1991 ; 88 (3). 811-816.
19. Hill MR, Stith RD, McCallum RE Interleukin 1: a regulatory role in glucocorticoid-regulated hepatic metabolism. J Immunol. 1986 ; 137 (3). 858-862.
20. Lang CH, Dobrescu C., Bagby GJ Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology. 1992 ; 130 (1). 43-52.
21. Wolfe RR, Herndon DN, Jahoor F., Miyoshi H., Wolfe M. Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med. 1987 ; 317 (7). 403-408.
22. Wolfe RR, Durkot MJ, Allsop JR, Burke JF Glucose metabolism in severely burned patients. Metabolism. 1979 ; 28 (10). 1031-1039.
23. Ma Y., Toth B., Keeton AB, Holland LT, Chaudry IH, Messina JL Mechanisms of hemorrhage-induced hepatic insulin resistance: role of tumor necrosis factor-alpha. Endocrinology. 2004 ; 145 (11). 5168-5176.
24. de Alvaro C., Teruel T., Hernandez R., Lorenzo M. Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. J Biol Chem. 2004 ; 279 (17). 17070-17078.
25. Ljungqvist O., Nygren J., Thorell A. Insulin resistance and elective surgery. Surgery. 2000 ; 128 (5). 757-760.
26. Nygren J., Soop M., Thorell A., Efendic S., Nair KS, Ljungqvist O. Preoperative oral carbohydrate administration reduces postoperative insulin resistance. Clin Nutr. 1998 ; 17 (2). 65-71.
27. Van den Berghe G., Wouters PJ, Bouillon R., et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003 ; 31 (2). 359-366. (Pubitemid 36232926)
28. Davidson PC, Steed RD, Bode BW Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. Diabetes Care. 2005 ; 28 (10). 2418-2423.
29. Boord JB, Sharifi M., Greevy RA, et al. Computer-based insulin infusion protocol improves glycemia control over manual protocol. J Am Med Inform Assoc. 2007 ; 14 (3). 278-287.
30. Souba WW Nutritional support. N Engl J Med. 1997 ; 336 (1). 41-48.
31. Knaus WA, Draper EA, Wagner DP, Zimmerman JE Apache II: a severity of disease classification system. Crit Care Med. 1985 ; 13 (10). 818-829.
32. Baker SP, O'Neill B., Haddon W. Jr, Long WB The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974 ; 14 (3). 187-196.
33. Dhindsa S., Tripathy D., Sanalkumar N., et al. Free fatty acid-induced insulin resistance in the obese is not prevented by rosiglitazone treatment. J Clin Endocrinol Metab. 2005 ; 90 (9). 5058-5063.
34. Ghanim H., Aljada A., Daoud N., Deopurkar R., Chaudhuri A., Dandona P. Role of inflammatory mediators in the suppression of insulin receptor phosphorylation in circulating mononuclear cells of obese subjects. Diabetologia. 2007 ; 50 (2). 278-285.
35. Pickup JC, Chusney GD, Thomas SM, Burt D. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci. 2000 ; 67 (3). 291-300.
36. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C., Smith H. Infection and diabetes: the case for glucose control. Am J Med. 1982 ; 72 (3). 439-450.
37. Geerlings SE, Hoepelman AI Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999 ; 26 (3-4). 259-265.
38. Mesotten D., Swinnen JV, Vanderhoydonc F., Wouters PJ, Van den Berghe G. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab. 2004 ; 89 (1). 219-226.
39. Vanhorebeek I., De VR, Mesotten D., Wouters PJ, De Wolf-Peeters C., Van den Berghe G. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet. 2005 ; 365 (9453). 53-59.
40. Ferrando AA, Wolfe RR Restoration of hormonal action and muscle protein. Crit Care Med. 2007 ; 35 (9 suppl). S630 - S634.
41. Ferrando AA Anabolic hormones in critically ill patients. Curr Opin Clin Nutr Metab Care. 1999 ; 2 (2). 171-175.
42. Hansen TK, Thiel S., Wouters PJ, Christiansen JS, Van den Berghe G. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab. 2003 ; 88 (3). 1082-1088.
43. Das UN Insulin: an endogenous cardioprotector. Curr Opin Crit Care. 2003 ; 9 (5). 375-383.
44. Finney SJ, Zekveld C., Elia A., Evans TW Glucose control and mortality in critically ill patients. JAMA. 2003 ; 290 (15). 2041-2047.
45. Dortch MJ, Mowery NT, Ozdas A., Dossett L., Cao H., Collier B., Holder G., Miller RA, May AK A computerized insulin infusion titration protocol improves glucose control with less hypoglycemia compared to a manual titration protocol in a trauma intensive care unit. JPEN J Parenter Enteral Nutr. 2008 Jan-Feb; 32 (1). 18-27.
46. Kwoun MO, Ling PR, Lydon E., et al. Immunologic effects of acute hyperglycemia in nondiabetic rats. JPEN J Parenter Enteral Nutr. 1997 ; 21 (2). 91-95.
47. Kehlet H., Brandt MR, Hansen AP, Alberti KG Effect of epidural analgesia on metabolic profiles during and after surgery. Br J Surg. 1979 ; 66 (8). 543-546. (Pubitemid 10234331)
48. Lattermann R., Schricker T., Wachter U., Georgieff M., Goertz A. Understanding the mechanisms by which isoflurane modifies the hyperglycemic response to surgery. Anesth Analg. 2001 ; 93 (1). 121-127.
49. Werb MR, Zinman B., Teasdale SJ, Goldman BS, Scully HE, Marliss EB Hormonal and metabolic responses during coronary artery bypass surgery: role of infused glucose. J Clin Endocrinol Metab. 1989 ; 69 (5). 1010-1018.